LEXINGTON, Ky. (Jan. 26, 2021) — Newly published research has found familiar music can elicit an extended emotional response in patients with Alzheimer’s-type dementia. The findings from this potential new approach were featured in issue three of volume 78 of the Journal of Alzheimer’s Disease.
News
LEXINGTON, Ky. (Feb. 25, 2021) — Spinal cord injuries (SCIs) are not only life-threatening at the time of the event, but they can also lead to secondary complications and loss of function in sensory and motor systems. Researchers at the University of Kentucky recently published a unique study focusing on SCIs in eNeuro.
LEXINGTON, Ky. (Feb. 5, 2021) — The early prognosis of high-risk older adults for amnestic mild cognitive impairment (aMCI), using non-invasive and sensitive neuromarkers, is key for early prevention of Alzheimer’s disease.
LEXINGTON, Ky. (Jan. 20, 2021) — More than 5.7 million Americans live with Alzheimer’s disease and that number is projected to triple by 2050. Despite that growing number, there is not yet a cure.
Daniel Lee, PhD, is an associate professor at the University of Kentucky College of Medicine Department of Neuroscience and a researcher at the UK Sanders-Brown Center on Aging, an internationally recognized Alzheimer’s Disease Research Center. He joined the UK College of Medicine in August 2019. He is also a member of the Faculty of Color Network and currently serves as co-director for the Research Education Component (REC) of the UK-ADRC.
LEXINGTON, Ky. (Nov. 24, 2020) — Linda J. Van Eldik, director of the Sanders-Brown Center on Aging at the University of Kentucky, has been named a Fellow of the American Association for the Advancement of Science (AAAS). Election as an AAAS Fellow is an honor bestowed upon AAAS members by their peers.
LEXINGTON, Ky. (Nov. 20, 2020) — The statistics on Alzheimer’s and dementia inducing brain disease are frightening to look at, and unlike research into cancer and heart disease, researchers have often been frustrated in their efforts to make progress in understanding these diseases.
LEXINGTON, KY. (Oct. 27, 2020) — A $2.9 million grant from the National Institutes of Health (NIH) is supporting a multidisciplinary team of University of Kentucky researchers in continuing their work to find therapeutic strategies to resolve neurovascular inflammation and repair blood-brain barrier dysfunction in epilepsy.
LEXINGTON, Ky. (Nov. 2, 2020) — In celebration of National Alzheimer’s Disease Awareness Month and National Family Caregiver’s Month, from Wednesday, Nov. 4 to Friday, Nov. 6, the William T. Young Library will shine purple to show the University of Kentucky's commitment to a world without Alzheimer's disease and to commemorate the important work done by caregivers.
Scientific Session
Monday, November 9, 2020
9:50 am - 2:00 pm via Zoom
Register Here
LEXINGTON, Ky. (Aug. 25, 2020) — Working with their colleagues at the University of Pennsylvania, researchers at the University of Kentucky have found that they can differentiate between subtypes of dementia inducing brain disease.
LEXINGTON, Ky. (Aug. 25, 2020) — Research looking at a possible new therapeutic approach for Alzheimer’s disease was recently published in the Journal of Neuroinflammation.
The Lexington Walk to End Alzheimer's is Saturday, September 12th so wear purple, get out & walk around town!
To join our team, click here!
The COVID-19 pandemic has impacted research, outcomes, long-term care and disparities related to Alzheimer’s disease and other dementias, according to presenters at the Alzheimer’s Association International Conference 2020.
Regarding its effects on research, Gregory Jicha, MD, PhD, chair of the Alzheimer’s Association Clinical Trials Advancement and Methods professional interest area, highlighted steps to safely conduct Alzheimer’s disease-related studies in the current pandemic environment.
Complete the Race anytime between Friday, August 14 and Saturday, August 29, 2020 for the Virtual Morning Light 5k to help raise money for UK Sanders-Brown Center on Aging!
Race fee includes race t-shirt. Medals will be awarded for top performers in each age category.
$25 for Early Bird registration until July 31st.
$30 for registration starting August 1st.
To register, click here.
LEXINGTON, Ky. (July 30, 2020) —The COVID-19 pandemic brought many things to a screeching halt and continues to impact our daily lives. However, important research at the University of Kentucky’s Sanders-Brown Center on Aging (SBCoA) is continuing under extreme caution and deep dedication.
“It can’t wait,” said Dr. Greg Jicha, a neurologist at SBCoA.
LEXINGTON, Ky. (July 29, 2020) — Alzheimer’s disease (AD) is the most common form of dementia among the elderly and currently there is no cure for the disease. The hallmarks of AD are the Aβ plaques and tau tangles found throughout the patient’s brain. For the past several decades, much of the work to find a treatment for AD has been focused on eliminating those dreaded Aβ plaques, by assuming that memory could be restored by removing the plaques.
LEXINGTON, Ky. (July 17, 2020) — Researchers at the University of Kentucky Sanders-Brown Center on Aging (SBCoA) recently screened the first participant in the world for what is known as the AHEAD 3-45 study. This work is looking at a study medication, BAN2401, to determine if it can help prevent worsening memory and thinking among individuals who might be at risk for future decline. They are hoping this study finds that BAN2401 does just that and will ultimately help prevent Alzheimer’s disease.